Mar 13, 2019 / 06:05PM GMT
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
All right. Thanks everyone for joining us here. It is my pleasure to have Abbott Laboratories here for this session. Again, I'm Kristen Stewart, the medical supplies and device analyst. And I have Brian Yoor, the CFO.
I have one audience question for you guys just to kind of key up the conversation. I wanted to get your thoughts on how you view Abbott's sustainable organic growth rate for the next 3 years. So you've got choices ranging between less than 4% up to greater than 10%. I'll do the countdown, and you guys can record your responses starting now. So count down.
(Voting)
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
All right. Brian, are you nervous?
Brian B. Yoor - Abbott Laboratories - Executive VP of Finance & CFO
No. It's my favorite question.
Kristen Marie Stewart - Barclays Bank PLC, Research Division - Research Analyst
All
Abbott Laboratories at Barclays Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot